Article
PLK1 inhibition selectively kills ARID1A deficient cells through uncoupling of oxygen consumption from ATP production
2021-06-02
Abstract excerpt
Inhibitors of the mitotic kinase PLK1 yield objective responses in a subset of refractory cancers. However, PLK1 overexpression in cancer does not correlate with drug sensitivity, and the clinical development of PLK1 inhibitors has been hampered by the lack of patient selection marker. Using a high-throughput chemical screen, we discovered that cells deficient for the tumor suppressor ARID1A are highly sensitive t...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 5e7d4efd-05fb-59d3-81a3-1d258d00c888
- DOI
- 10.1101/2021.06.01.446664
